Starpharma Holdings Limited (ASX:SPL)
Australia · Delayed Price · Currency is AUD 0.4900
+0.0150 (3.16%)
Feb 19, 2026, 4:10 PM AEST
Starpharma Holdings Market Cap
Starpharma Holdings has a market cap or net worth of 199.46 million as of February 18, 2026. Its market cap has increased by 377.05% in one year.
Market Cap
199.46M
Enterprise Value
182.00M
Revenue
14.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.49
Market Cap Chart
Since September 28, 2000, Starpharma Holdings's market cap has increased from 50.00M to 199.46M, an increase of 298.92%. That is a compound annual growth rate of 5.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 18, 2026 | 199.46M | 32.48% |
| Dec 31, 2025 | 150.56M | 227.36% |
| Dec 31, 2024 | 45.99M | -34.30% |
| Dec 29, 2023 | 70.01M | -68.87% |
| Dec 30, 2022 | 224.87M | -58.74% |
| Dec 31, 2021 | 544.95M | -14.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 403.01M |
| Dimerix | 288.19M |
| Orthocell | 249.60M |
| Tetratherix | 197.99M |
| Recce Pharmaceuticals | 170.62M |
| Actinogen Medical | 147.13M |
| Botanix Pharmaceuticals | 130.03M |
| Paradigm Biopharmaceuticals | 129.58M |